SCHEMBL25820779

SCHEMBL25820779

O=C(c1cccc(Nc2ccnc3ccc(F)cc23)c1)N1CCc2c(Oc3ccccc3)cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.42
DNMT3A Q9Y6K1 1/20 0.42
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
GAK O14976 2/20 0.41
CDK8 P49336 2/20 0.40
CCNC P24863 1/20 0.40
UCHL1 P09936 1/20 0.39
DHODH Q02127 1/20 0.39
ALDH1A1 P00352 2/20 0.39
PDGFRB P09619 2/20 0.38
ERBB2 P04626 1/20 0.38
TGFBR1 P36897 1/20 0.38
CLK2 P49760 1/20 0.37
ACVR1 Q04771 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
MTOR P42345 1/20 0.37
MET P08581 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25488283 0.94 GAK (0.40) DNMT1DNMT3AGAAHTTGAK
SCHEMBL25820769 0.90 DNMT1 (0.46) DNMT1DNMT3AGAAHTTGAK
SCHEMBL25820778 0.88 ALDH1A1 (0.50) GAAHTTUCHL1DHODHALDH1A1
SCHEMBL24009942 0.85 DNMT1 (0.43) DNMT1DNMT3AGAAHTTGAK
SCHEMBL30290923 0.85 DNMT1 (0.43) DNMT1DNMT3AGAAHTTGAK
SCHEMBL25488284 0.84 ALDH1A1 (0.46) GAAHTTDHODHALDH1A1LMNA
SCHEMBL25820818 0.81 UCHL1 (0.42) UCHL1ALDH1A1MEN1KMT2A
SCHEMBL25820804 0.81 UCHL1 (0.45) GAAHTTUCHL1ALDH1A1MEN1
SCHEMBL30290895 0.79 DNMT1 (0.44) DNMT1DNMT3AGAAHTTGAK
SCHEMBL24010132 0.79 DNMT1 (0.44) DNMT1DNMT3AGAAHTTGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885GAA 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.